Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research
The Scientist
Most Recent
Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.
Tailoring ethical oversight to participant-led research
Nanoparticles coated with a toxin found in bee venom can destroy HIV while leaving surrounding cells intact.
If African-American researchers are ever to gain equal opportunities in science, even subtle cases of differential treatment must be stamped out.
Normal proteins with regions resembling disease-causing prions are responsible for an inherited disorder that affects the brain, muscle, and bone.
Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Contrary to previous assumptions that macrolide antibiotics completely block the exit tunnel of ribosomes, new evidence shows that some peptides are allowed to pass.
Fueled by donations, sweat, and occasional dumpster diving, community laboratories for DIY biologists are cropping up around the country.
In Chapter 1, “The Coldest Case,” author and criminal profiler Pat Brown sets the scene for her quest to prove that the Egyptian queen did not commit suicide.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
